Active compounds present inRosmarinus officinalis leaves andScutellaria baicalensis root evaluated as new therapeutic agents for endometriosis
Other
OA: bronze
CC0
⤵ 20 in-corpus citations
AI-generated summary
Carnosic acid, rosmarinic acid, and wogonin inhibited human endometrial stromal cell growth in vitro and reduced endometriotic lesion size in mice.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
RESEARCH QUESTION: Can carnosic acid, (CA) rosmarinic acid (RA) and wogonin (WG) inhibit the growth of cultured human endometrial stromal cells and endometriotic-like lesions induced in a BALB/c model of endometriosis?
DESIGN: Primary stromal cell cultures were established from endometrial biopsies from women with endometriosis and controls. The human endometrial stromal cell line T-HESC was also used for in-vitro experiments. Endometriosis was surgically induced in BALB/c mice, which were randomly assigned to CA 2 mg/kg/day (n = 11); CA 20 mg/kg/day (n = 10); RA 1 mg/kg/day (n = 11); RA 3 mg/kg/day (n = 10); WG 20 mg/kg/day (n = 12); intraperitoneal vehicle control (n = 8) or oral vehicle control (n = 11). After surgery, CA and RA were administered intraperitoneally on days 14-28. WG was administered orally by intragastric gavage on days 14-26.
RESULTS: CA, RA and WG significantly inhibited in-vitro cell proliferation in primary and T-HESC cell cultures (P < 0.05). CA and WG induced cell cycle arrest of T-HESC at the G2/M phase (P < 0.01). RA reduced intracellular ROS accumulation (P < 0.001), whereas WG increased it (P < 0.05). WG significantly inhibited oestrogen receptor alpha expression in T-HESC (P < 0.01). In-vivo, CA, RA and WG significantly reduced lesions size (P < 0.05). All compounds significantly decreased the percentage of cells in proliferation (P < 0.05) whereas RA and WG further increased the percentage of apoptotic cells (P < 0.05) in endometriotic-like lesions.
CONCLUSIONS: The results are promising; further investigation of these compounds as new therapeutics is needed.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (64)
- Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis via openalex
- Chinese herbal medicine for endometriosis via openalex
- Early-stage endometriosis: adhesion and growth of human menstrual endometrium in nude mice via openalex
- Effects of 1,25-Dihydroxy Vitamin D3 on Endometriosis via openalex
- Endometriosis via openalex
- Endometriosis: alternative methods of medical treatment via openalex
- Endometriosis: epidemiology and aetiological factors via openalex
- Endometriosis: pathogenesis and treatment via openalex
- Interplay between Endometriosis and Pregnancy in a Mouse Model via openalex
- Natural therapies assessment for the treatment of endometriosis via openalex
- On-label and off-label drug use in the treatment of endometriosis via openalex
- Oxidative stress and peritoneal endometriosis via openalex
- Oxidative Stress Statues in Serum and Follicular Fluid of Women with Endometriosis via openalex
- Pathogenesis and pathophysiology of endometriosis via openalex
- Reactive oxygen species controls endometriosis progression via openalex
- Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Targeting oxidative stress to treat endometriosis via openalex
- The inhibitory effect of celecoxib and rosiglitazone on experimental endometriosis via openalex
- Western herbal medicine, epigenetics, and endometriosis via openalex
- W2073400731 via openalex
- W2076358165 via openalex
- W2080193116 via openalex
- W2096074702 via openalex
- W2096747133 via openalex
- W2099367290 via openalex
- W2109069677 via openalex
- W2109250250 via openalex
- W1531664873 via openalex
- W2129778797 via openalex
- W2133275245 via openalex
- W2150183703 via openalex
- W2159657185 via openalex
- W2167791591 via openalex
- W2397708414 via openalex
- W2423506215 via openalex
- W2551193853 via openalex
- W4211081176 via openalex
- W4293247451 via openalex
- W6605975336 via openalex
- W6650176428 via openalex
- W6676289522 via openalex
- W6733140239 via openalex
- W7075575911 via openalex
- W2128635872 via openalex
- W1536685388 via openalex
- W1906106315 via openalex
- W1978288476 via openalex
- W1994023284 via openalex
- W1997862837 via openalex
- W2000016625 via openalex
- W2003287009 via openalex
- W2007792010 via openalex
- W2008821352 via openalex
- W2018648986 via openalex
- W2023658004 via openalex
- W2024405339 via openalex
- W2024421129 via openalex
- W2027388324 via openalex
- W2037859648 via openalex
- W2038495453 via openalex
- W2063299574 via openalex
- W2065294001 via openalex
- W2069126054 via openalex
Cited by (25)
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Therapeutic Potential of Rosmarinus officinalis Extract on Endometriosis: Evidence from In Vitro Models 2026
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Polyphenols as Modulators of Oxidative Stress and Inflammation in Endometriosis: Molecular Mechanisms and Clinical Perspectives 2026
- Multi-Target Modulation of Interconnected Pathogenetic Pathways by Natural Bioactive Compounds in Endometriosis 2026
- Phytochemicals in the Management of Polycystic Ovary Syndrome, Endometriosis, and Menstrual Irregularities 2025
- Regulated cell death in endometrial diseases: from molecular mechanisms to targeted therapies 2025
- Natural bioactive compounds and herbal medicines targeting common signaling pathways in endometriosis: mechanisms and therapeutic implications 2025
- Research progress on natural plant metabolites targeting apoptosis for endometriosis prevention and treatment: a systematic review 2025
- Natural compounds for endometriosis and related chronic pelvic pain: A review 2024
- The effect of a standardized polyherbal formulation for endometriosis-associated pain: A randomized double-blind placebo-controlled clinical trial 2024
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Insight into the Potential Mechanisms of Endocrine Disruption by Dietary Phytoestrogens in the Context of the Etiopathogenesis of Endometriosis 2023
- Effects of pharmacological inhibition of hyaluronic acid synthesis on experimental endometriosis 2022
- The Phytochemical Profile and Biological Activity of Malva neglecta Wallr. in Surgically Induced Endometriosis Model in Rats 2022
- INTEGRATIVE CHINESISCHE MEDIZIN AM BEISPIEL DER BEHANDLUNG VON ENDOMETRIOSE 2022
- Endometriosis and Phytoestrogens: Friends or Foes? A Systematic Review 2021
- Effect of urolithins A and B on ectopic endometrial growth in a murine model of endometriosis 2021
- Faculty Opinions recommendation of Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives. 2021
- Polyphenols as a Diet Therapy Concept for Endometriosis-Current Opinion and Future Perspectives 2021
- Homing Peptide-Based Targeting of Tenascin-C and Fibronectin in Endometriosis 2021
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology 2021
- The Effect of Rutin and Extracts of Uncaria guianensis (Aubl.) J. F. Gmeland on Primary Endometriotic Cells: A 2D and 3D Study 2020
- Potential use of ellagic acid for endometriosis treatment: its effect on a human endometrial cell cycle, adhesion and migration 2020
- Plants as source of new therapies for endometriosis: a review of preclinical and clinical studies 2020
Source provenance
- europepmc
- last seen: 2026-10-28T06:16:56.634860+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-10-08T21:23:25.915063+00:00
License: CC0
· commercial use OK